{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:22:40Z","timestamp":1765736560998,"version":"3.48.0"},"reference-count":23,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shanghai Hospital Development Center Three-Year Action Plan for Promoting Clinical Skills and Innovation Ability of Municipal Hospitals","award":["SHDC2022CRD045"],"award-info":[{"award-number":["SHDC2022CRD045"]}]},{"name":"Clinical Research Program of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["JYLJ202014"],"award-info":[{"award-number":["JYLJ202014"]}]},{"name":"Biobank for Coronary Heart Disease of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["YBKA202206"],"award-info":[{"award-number":["YBKA202206"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,14]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The purpose of this study is to evaluate the safety and efficacy of two different antithrombotic strategies, dual antiplatelet therapy (DAPT, aspirin and ticagrelor) and direct oral anticoagulant (DOAC, rivaroxaban), after left atrial appendage closure (LAAC) using the LACbes occluder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This study is a prospective, randomised, controlled and multicentre clinical trial that will compare the clinical efficacy of antiplatelet and anticoagulation therapy after LAAC with the LACbes occluder. It is planned to enrol 296 subjects with non-valvular atrial fibrillation (NVAF) who complete transcatheter closure of the left atrial appendage successfully. All subjects who pass the screening process and sign informed consent forms will be randomised in a 1:1 ratio to the DAPT group (aspirin 100\u2009mg\/day and ticagrelor 90\u2009mg two times a day) or the DOAC group (rivaroxaban 15\u2009mg\/day). Baseline data within 24 hours after the operation and follow-up information at 3, 6 and 12 months will be recorded to investigate the difference in the incidence of device-related thrombosis, clinical thrombotic events, bleeding and other adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval has been obtained from the Ethics Committee of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Approval number SH9H-2022-T426-1). The protocol (Version: V1, 20230105) has also been submitted and approved by the institutional ethics committee at each participating centre. Results are expected in 2025 and will be disseminated through peer-reviewed journals and presentations at national and international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2100046712.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration name<\/jats:title>\n                    <jats:p>Different antithrombotic strategies after left atrial appendage closure with the LACbes occluder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-084351","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T04:15:39Z","timestamp":1742530539000},"page":"e084351","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Different antithrombotic strategies after left atrial appendage closure with the LACbes occluder: protocol of the DAAL trial"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-4302","authenticated-orcid":false,"given":"Tiantian","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cailan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengde","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"2025121410173192000_15.3.e084351.1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"ESC Scientific Document Group","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"2025121410173192000_15.3.e084351.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659"},{"key":"2025121410173192000_15.3.e084351.3","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(18)30356-9"},{"key":"2025121410173192000_15.3.e084351.4","article-title":"Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study","volume":"23","author":"Shi","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"2025121410173192000_15.3.e084351.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.05.015"},{"key":"2025121410173192000_15.3.e084351.6","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jtha.2023.04.021","article-title":"News at XI: moving beyond factor Xa inhibitors","volume":"21","author":"Fredenburgh","year":"2023","journal-title":"J Thromb Haemost"},{"key":"2025121410173192000_15.3.e084351.7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10840-020-00884-x","article-title":"Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study)","volume":"59","author":"Flores-Umanzor","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"2025121410173192000_15.3.e084351.8","doi-asserted-by":"publisher","DOI":"10.7326\/M20-6194"},{"key":"2025121410173192000_15.3.e084351.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-590323"},{"key":"2025121410173192000_15.3.e084351.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"2025121410173192000_15.3.e084351.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care","volume":"362","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"key":"2025121410173192000_15.3.e084351.12","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00887-X"},{"key":"2025121410173192000_15.3.e084351.13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/HCO.0000000000000818","article-title":"Percutaneous left atrial appendage occlusion","volume":"36","author":"Mohammed","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"2025121410173192000_15.3.e084351.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.067"},{"key":"2025121410173192000_15.3.e084351.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.023"},{"key":"2025121410173192000_15.3.e084351.16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"2025121410173192000_15.3.e084351.17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"2025121410173192000_15.3.e084351.18","first-page":"937","article-title":"2019 Chinese Society of Cardiology (CSC) expert consensus statement on left atrial appendage closure in the prevention of stroke in patients with atrial fibrillation","volume":"47","year":"2019","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2025121410173192000_15.3.e084351.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.047"},{"key":"2025121410173192000_15.3.e084351.20","first-page":"314","article-title":"Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients","volume":"21","author":"Zhai","year":"2019","journal-title":"Anatol J Cardiol"},{"key":"2025121410173192000_15.3.e084351.21","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.974994","article-title":"A newly designed disk-lobe occluder with isogenous barbs for left atrial appendage closure: Initial multicenter experience","volume":"9","author":"Bai","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025121410173192000_15.3.e084351.22","first-page":"710","article-title":"Research history and prospect of LACbes left atrial appendage occluder","volume":"32","author":"Tang","year":"2023","journal-title":"J Intervent Radiol"},{"key":"2025121410173192000_15.3.e084351.23","first-page":"1051","article-title":"Transcatheter closure of perimembranous ventricular septal defect using a novel fully bioabsorbable occluder: multicenter randomized controlled trial","volume":"68","author":"Wang","year":"2023","journal-title":"Sci Bull Sci Found Philipp"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-084351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:17:39Z","timestamp":1765736259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-084351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,18]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-084351"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-084351","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}